Sowell Financial Services LLC Aptevo Therapeutics Inc. Transaction History

Sowell Financial Services LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$21.85 - $30.0 $524 - $720	-24 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$27.86 - $40.59 $4,179 - $6,088	-150 Reduced 86.21%	24 $1,000
Q4 2020 Jan 13, 2021	BUY	$6.21 - $48.36 $1,080 - $8,414	174 New	174 $6,000

Ticker APVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,090,640
Market Cap $22.4M
Description
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.